Abstract:Obesity causes a wide variety of metabolic diseases including fatty liver disease and diabetes. Mechanistically, obesity‐associated inflammation has been implicated as a key factor in the development of fat deposition, insulin resistance, and metabolic dysregulation. However, the regulation of inflammation in obesity remains to be explored. As a member of the G‐protein coupled receptor families, adenosine 2A receptor (A 2A R) is ant‐inflammatory. However, little is known about nutritional regulation of A 2A R as it relates to insulin resistance. In the present study, the expression of A 2A R in liver and adipose tissue was examined in wild type (WT) C57BL/6J mice upon feeding a high‐fat diet (HFD) or a control low‐fat diet (LFD). Also, both A 2A R ‐deficient mice and WT C57BL/6J mice were fed an HFD or LFD for 12 weeks to examine the involvement of A 2A R in diet‐induced inflammation and insulin resistance. Lastly, the effects of major macronutrients, i.e., glucose and palmitate, on the inflammatory responses were examined in both WT and A 2A R‐deficient macrophages. Compared with LFD‐fed WT mice, HFD‐fed WT mice displayed obesity and obesity‐related inflammation in liver and adipose tissue and systemic insulin resistance. Interestingly, the levels of A 2A R in both the liver and adipose tissue of HFD‐fed WT mice were increased significantly compared with LFD‐fed mice. When comparing with HFD‐fed WT mice, HFD‐fed A2AR‐deficient mice displayed an significant increase in the severity of inflammation and insulin resistance. In cultured cells, the proinflammatory responses were much enhanced in A 2A R‐deficient macrophage in relative to WT cells regardless of palmitate treatment. Taken together, these results suggest that HFD feeding induces the expression of A 2A R, which in turn exerts a defensive role in protecting against inflammation and insulin resistance. Support or Funding Information This study was support in part by NIH grants. Also, Dr. Wu is supported by an NIFA program.

The Mab Against Adipocyte Fatty Acid-Binding Protein 2E4 Attenuates the Inflammation in the Mouse Model of High-Fat Diet-Induced Obesity Via Toll-Like Receptor 4 Pathway.

Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes

Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation

Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1

Adipocyte Fatty Acid Binding Protein Potentiates Toxic Lipids-Induced Endoplasmic Reticulum Stress in Macrophages Via Inhibition of Janus Kinase 2-Dependent Autophagy

Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).

Apolipoprotein A-IV Reduced Metabolic Inflammation in White Adipose Tissue by Inhibiting IKK and JNK Signaling in Adipocytes

FABP4 Reversed the Regulation of Leptin on Mitochondrial Fatty Acid Oxidation in Mice Adipocytes

L-4f Inhibits Oxidized Low-Density Lipoprotein-Induced Inflammatory Adipokine Secretion Via Cyclic Amp/Protein Kinase A-Ccaat/Enhancer Binding Protein Beta Signaling Pathway In 3t3-L1 Adipocytes

(EX-4)2-Fc, an effective long-acting GLP-1 receptor agonist, reduces obesity-related inflammation by inhibiting leptin expression

Attenuation of high‐fat diet‐induced weight gain by apolipoprotein A4

Adipocyte Inducible 6-Phosphofructo-2-kinase Suppresses Adipose Tissue Inflammation and Promotes Macrophage Anti-Inflammatory Activation

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases

Identification of New Dual FABP4/5 Inhibitors Based on a Naphthalene-1-sulfonamide FABP4 Inhibitor.

Dietary Effects on A(2a)R Expression in Liver and Adipose Tissues: A Role for A(2a)R in Protecting Against Inflammation and Insulin Resistance in Obesity

Regulation of adipose tissue inflammation by adenosine 2A receptor in obese mice.

The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation

Inhibition of Adipocyte-Derived FABP4 Reduces Adipocyte Inflammation, Improves Angiogenesis, and Facilitates Wound Healing in Metabolic Dysfunctions

Successful Reduction of Inflammatory Responses and Arachidonic Acid–cyclooxygenase 2 Pathway in Human Pulmonary Artery Endothelial Cells by Silencing Adipocyte Fatty Acid-Binding Protein

Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis